2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations

Figure 1. Echocardiographic image of a patient with primary, myxomatous mitral valve disease. Note the large jet of mitral regurgitation (arrowhead) attributed to a flail leaflet (asterisk). LA indicates left atrium; LV, left ventricle.

Figure 2. Echocardiographic image of a patient with secondary, functional mitral regurgitation. Note large jet of mitral regurgitation (arrowhead) attributed to leaflet tethering (asterisk) as a result of left ventricular remodeling. LA indicates left atrium; LV, left ventricle.

Figure 3. A, Short‐axis view of an MRI of a Sapien 3 TAVR valve with thrombus noted on left leaflet of the prosthesis (arrow). B, Long‐axis view of an MRI of a Sapien 3 TAVR valve with thrombus noted on left leaflet of the prosthesis (arrow). MRI indicates magnetic resonance imaging; TAVR, transcutaneous aortic valve replacement.

Figure 4. A, Transesophageal echo demonstrating a thrombosed mechanical heart valve in a patient that was noncompliant with warfarin therapy. Note the thrombus on the atrial side of the valve (arrowhead). B, Doppler interrogation of the thrombosed mechanical valve demonstrating severe mitral stenosis. PG indicates pressure gradient; VTI, velocity time integral.